Personal Satisfaction: Clinical Trials

2 trials for Personal Satisfaction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Recruiting 2

Follow Personal Satisfaction: new trials by email Literature Review of Personal Satisfaction trials Research Report on Personal Satisfaction

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Effectiveness of Hormonal Treatment in Adolescents Suffering From Gender Dysphoria
hormonal treatment with cross sex hormones (testosterone or oestrogenes) started at 14 years old +/- 6 months, Cross sex hormones ( œstrogenes or testosterone) started at 15.5 years old +/- 6 months - Gender Dysphoria
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris602024-06-252026-08-10
The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III
Vitamin D3 Drops, Coriolus Versicolor, Trident SAP 66:33 Lemon - Lung Cancer, Gastric Cancer
Phase 3RecruitingOttawa Hospital Research Institute202022-04-042026-01-30

Narrower conditions

Psychological Well-Being (2)  ·  Esophageal Neoplasms (1)  ·  Gender Dysphoria (1)  ·  Lung Neoplasms (1)  ·  Motor Activity (1)  ·  Stomach Neoplasms (1)

Broader conditions

Behavior (2)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Esophageal Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Lung Diseases (1)  ·  Mental Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Neoplasms (1)  ·  Sexual Dysfunctions, Psychological (1)

Interventions

Curcumin (1)  ·  Fish Oils (1)  ·  Probiotics (1)  ·  Tea (1)  ·  Testosterone (1)  ·  Vitamin D (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Ottawa Hospital Research Institute (1)

Countries

Canada (1)  ·  France (1)

Top investigators

Andrew Seely, MD, PhD, FRCSC (1)  ·  Dugald Seely, ND, MSc (1)

NIH funding

2019 (1)